Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 9 10 11 12 presentations: 1 to 50 of 591
Workshop: Program Committee Workshop for New Investigators and Trainees
A Path to an HIV Vaccine
Galit Alter
Ragon Institute of MIT, MGH and Harvard, Cambridge, MA, United States
from CROI 2015 on February 23, 2015 9:00 AM-12:30 PM
Workshop: Program Committee Workshop for New Investigators and Trainees
Animal Models of HIV Prevention and Cure
Guido Silvestri
Emory University, Decatur, GA, United States
from CROI 2015 on February 23, 2015 9:00 AM-12:30 PM
Workshop: Program Committee Workshop for New Investigators and Trainees
HIV Prevention 2.0: What's Next?
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, United States
from CROI 2015 on February 23, 2015 9:00 AM-12:30 PM
Workshop: Program Committee Workshop for New Investigators and Trainees
Pathogenesis of HIV Complications
Peter W. Hunt
University of California San Francisco, San Francisco, CA, United States
from CROI 2015 on February 23, 2015 9:00 AM-12:30 PM
Workshop: Program Committee Workshop for New Investigators and Trainees
HIV Cure Research
John M. Coffin
Tufts University, Boston, MA, United States
from CROI 2015 on February 23, 2015 9:00 AM-12:30 PM
Martin Delaney Presentation: How to End the HIV Epidemic: Community Perspectives
Moderator
Steven Wakefield
HIV Vaccine Trials Network, Seattle, WA, United States
Panelist
Connie Celum
International Clinical Research Center, University of Washington, Seattle, WA, United States
Panelist
Damon L. Jacobs
Private Practice, Brooklyn, NY, United States
Panelist
Matthew V. Sharp
Shanti Project, Berkeley, CA, United States
Questions and Answers
from CROI 2015 on February 23, 2015 1:00 PM-2:00 PM
Workshop: Clinical Trial Design and Analysis
Getting SMART About Innovative Designs for Studying Effectiveness: The Case of Adaptive Implementation Interventions
Daniel Almirall
University of Michigan, Ann Arbor, MI, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Clinical Trial Design and Analysis
The Clinical Pharmacology of Medication Adherence
Terrence Blaschke
Stanford University, Stanford, CA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Clinical Trial Design and Analysis
Epidemiological and Biostatistical Issues in Studying Rare Events in HIV
Stephen J. Gange
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Frontiers in Laboratory Science
Measuring Immunity 1 Cell at a Time
Mario Roederer
Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Frontiers in Laboratory Science
Studying Heterogeneity With Single Cell RNA-Sequencing
Simon Quenneville
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Frontiers in Laboratory Science
Integration-Site Analysis
Frederic D. Bushman
University of Pennsylvania School of Medicine, Philadelphia, PA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Frontiers in Laboratory Science
Discovery and Modeling of Genomic Regulatory Networks With Big Data
Hamid Bolouri
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Hepatitis C Care in the Interferon-Free Era
Acute HCV: Is It Still Important to Diagnose and Treat?
Arthur Y. Kim
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Hepatitis C Care in the Interferon-Free Era
Chronic Genotype 1 Infection
Debika Bhattacharya
University of California Los Angeles CARE Center, Los Angeles, CA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Hepatitis C Care in the Interferon-Free Era
HCV Genotype 3: Our Next Challenge
Arthur Y. Kim
Massachusetts General Hospital, Boston, MA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Hepatitis C Care in the Interferon-Free Era
HCV Cirrhotics With Early Decompensation
Marion G. Peters
University of California San Francisco, San Francisco, CA, United States
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Workshop: Hepatitis C Care in the Interferon-Free Era
Questions and Answers
from CROI 2015 on February 23, 2015 2:30 PM-4:30 PM
Opening Session
Opening Session Host
Scott M. Hammer
Columbia University Medical Center/New York-Presbyterian
Hospital, New York, NY, United States
from CROI 2015 on February 23, 2015 5:00 PM-5:30 PM
Opening Session
Bernard Fields Lecture: Hepatitis C: Light at the End of the Tunnel
Charles M. Rice
The Rockefeller University, New York, NY, United States
from CROI 2015 on February 23, 2015 5:00 PM-5:30 PM
Opening Session
N'Galy-Mann Lecture: Antiretroviral Therapy: Past, Present, and Future
David A. Cooper
Kirby Institute, University of New South Wales, Sydney, Australia
from CROI 2015 on February 23, 2015 6:00 PM-6:30 PM
Opening Session
Tribute to Malaysia Air Flight #17
Scott M. Hammer
Columbia University Medical Center/New York-Presbyterian
Hospital, New York, NY, United States
from CROI 2015 on February 23, 2015 6:00 PM-6:30 PM
Plenary
PrEP for HIV Prevention: What We Know and What We Still Need to Know for Implementation
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
from CROI 2015 on February 24, 2015 8:30 AM-9:00 AM
Plenary
Specific HIV Integration Sites Linked to Clonal Expansion and Persistence of Cells
Stephen H. Hughes
National Cancer Institute, Frederick, MD, United States
from CROI 2015 on February 24, 2015 9:00 AM-9:30 AM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
Envelope Trimer Numbers Required for Entry Steer HIV-1 Infectivity and Entry Kinetics
Alexandra Trkola
University of Zurich, Zurich, Switzerland
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
HIV-1 Accessory Protein Function: Evaluating VPU-Dependent Host Factor Degradation
Prashant Jain
Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
HIV-1 Adaptation to Humans Involved Interactions of Vpr With the DNA Damage Response
Oliver I. Fregoso
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
The HIV-1 Protease Can Interact With RNA to Dramatically Enhance Its Activity
Marc Potempa
University of North Carolina, Chapel Hill, NC
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
PQBP1 Is a Retrovirus-Specific Sensor Mediating cGAS/IRF3-Dependent Innate Responses
Sunnie M. Yoh
Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
Mucosal HIV-1 Transmission Specifically Selects for Type 1 Interferon-Resistant Viruses
Shilpa Iyer
University of Pennsylvania, Philadelphia, PA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
The Dynamics of HIV-1 RNA Near the Plasma Membrane During Virus Assembly
Luca Sardo
Frederick National Laboratory for Cancer Research, Frederick, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction
Mechanisms of Dendritic Cell-Mediated Transfer of HIV-1 to CD4+ T Lymphocytes
Mickael M. Menager
Skirball Institute of Biomolecular Medicine, New York, NY, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:00 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
Inflammation Persists Despite Early Initiation of ART in Acute HIV Infection
Netanya S. Utay
University of Texas Medical Branch at Galveston, Galveston, TX, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
HIV Burden and Biomarker Associations With Colonic HIV RNA During Acute HIV Infection
Trevor A. Crowell
US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
Identification and Characterization of Individual HIV-Infected CD4 T Cells Ex Vivo
Joseph Casazza
Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
Efficacy of HIV-1 Monoclonal Antibody Immunotherapy in Acute SHIV-Infected Macaques
Diane L. Bolton
US Military HIV Research Program, Silver Spring, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
HIV-1 Infections With Multiple Founders Are Associated With Higher Viral Loads
Morgane Rolland
US Military HIV Research Program, Silver Spring, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
Post-Treatment Controllers Have Particular NK Cells With High Anti-HIV Capacity: VISCONTI Study
Daniel Scott-Algara
Institut Pasteur, Paris, France
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
Antiretroviral Therapy Preserves Polyfunctional HIV-1–Specific CD8 T Cells With Stem-Cell–Like Properties
Selena Vigano
The Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
In Vitro Replication and Interferon-Alpha Resistance of Transmitted HIV-1 Variants
Zachary Ende
Emory University, Atlanta, GA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: New Discoveries in HIV Pathogenesis
HVTN505 Breakthrough Sequences Show HIV Vaccine-Associated Differences in Env-gp120
Morgane Rolland
US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Silver Spring, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study
Sheena McCormack
MRC Clinical Trials Unit at University College London, London, United Kingdom
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial
Jean-Michel Molina
University of Paris Diderot, Paris, France
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Near Elimination of HIV Transmission in a Demonstration Project of PrEP and ART
Jared Baeten
University of Washington, Seattle, WA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Scale-Up of Preexposure Prophylaxis in San Francisco to Impact HIV Incidence
Robert M. Grant
Gladstone Institutes, San Francisco, CA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women
Helen Rees
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Effect of Oral and Gel Tenofovir on Genital HSV Shedding in Immunocompetent Women
Rachel A. Bender Ignacio
University of Washington, Seattle, WA, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Injectable Hormonal Contraception Use and Women's Risk for HSV-2 Acquisition
Mary K. Grabowski
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Effect of Financial Incentives on Linkage to Care and Viral Suppression: HPTN 065
Wafaa M. El-Sadr
ICAP at Columbia University, New York, NY, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
Oral Abstract: Preventing HIV and HSV-2: What Will It Take?
Medical Male Circumcision of HIV-Infected Men Reduces Long-Term Penile HIV Shedding
Jordyn L. Manucci
Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2015 on February 24, 2015 10:00 AM-12:15 PM
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 9 10 11 12 presentations: 1 to 50 of 591